Description

Fluxen (fluoxetine) capsules 0.02 g. №10

Ingredients

Active ingredient: Fluoxetine 0.02 g.
Other ingredients: lactose, corn starch, talc, gelatin, titanium dioxide, and colorants.

Dosage

Dosage: The usual dose is 20 mg to 80 mg daily, taken as a single dose in the morning or divided into two doses.

Indications

Indicated for: Major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, panic disorder, and premenstrual dysphoric disorder.

Contraindications

Contraindications: Do not use Fluxen if you are taking monoamine oxidase inhibitors (MAOIs) or thioridazine.

Directions

Directions: Swallow the capsule whole with water. Do not crush or chew the capsule.

Scientific Evidence

Fluoxetine, the active ingredient in Fluxen, is a selective serotonin reuptake inhibitor (SSRI) that works by increasing serotonin levels in the brain. Studies have shown that fluoxetine is effective in treating various mental health conditions, including depression and anxiety disorders. Research published in the Journal of Clinical Psychiatry demonstrated the efficacy of fluoxetine in reducing symptoms of major depressive disorder.

Additional Information

Fluxen is well-tolerated by most patients, with common side effects including nausea, headache, and insomnia. It is important to follow the prescribed dosage and not to discontinue the medication abruptly. Consult your healthcare provider for personalized advice on using Fluxen.

Fluoxetine, the active ingredient in Fluxen, exerts its pharmacological effects by inhibiting the reuptake of serotonin in the brain, leading to increased levels of this neurotransmitter. Serotonin plays a crucial role in regulating mood, emotions, and behavior, making fluoxetine a valuable medication in the treatment of various psychiatric disorders.

Clinical trials have shown that Fluxen is comparable in efficacy to other SSRIs in the treatment of depression and anxiety disorders. A study published in the Journal of Affective Disorders found no significant differences in effectiveness between fluoxetine and other SSRIs, highlighting its role as a first-line treatment option for these conditions.